(1)
Guan, J.; Yang, Q.; Chen, C.; Wang, G.; Zhu, H. Prognostic Value of Low Skeletal Muscle Mass in Hepatocellular Carcinoma Patients Treated With Sorafenib or Lenvatinib: A Meta-Analysis. EXCLI J. 2021, 20, 1-16.